Back to Pinealon research
pinealon preclinical animal n preclinical 2026-04-24 PubMed

Peptide Geroprotectors Improve Learning and Modulate Brain Caspase-3 in Aging Rats

[Effect of peptide geroprotectors on the navigation system learning and caspase-3 in brain structures in rats of different age].

Background

Aging is often accompanied by cognitive decline and neurodegenerative processes, which can severely impact quality of life. Geroprotectors, substances designed to slow down or reverse aspects of aging, are being explored for their potential to mitigate these effects. This study specifically aimed to understand how two peptide geroprotectors, Cortexin and Pinealon, influence learning abilities and the activity of caspase-3, a key enzyme in cell death pathways, within the brains of rats across different age groups.

Study Design

Population
Young and old rats were studied to understand age-related cognitive decline and neurodegenerative processes.
Intervention
Pinealon and Cortexin were administered as peptide geroprotectors; dose, route, and duration are not specified.
Comparator
Cortexin served as an active comparator to Pinealon.
Outcome
The primary outcome measured was navigation learning ability in the Morris labyrinth and the activity and content of caspase-3 in the cerebral cortex and brainstem.

Results

The investigation revealed significant regional alterations in the activity and content of caspase-3 within the cerebral cortex and brainstem of young and old rats following peptide administration. These findings suggest that the functional state of caspase-3 in the brain plays a crucial role in determining an animal's capacity for learning. The study highlighted a differential effect between the two peptides: > Pinealon demonstrated a prevalent positive effect on navigation learning in the Morris labyrinth for both young and old animals when compared to Cortexin. This indicates that Pinealon was more effective in enhancing cognitive performance across different age groups, suggesting a robust pro-cognitive benefit.

Why It Matters

This research underscores the potential of peptide geroprotectors as novel therapeutic agents for combating age-related cognitive decline and neurodegenerative diseases. The finding that Pinealon exerts a prevalent positive effect on learning in both young and old animals is particularly significant. This broad efficacy across age groups suggests Pinealon could be a promising candidate for developing interventions against cognitive impairment, potentially leading to future clinical applications for conditions like Alzheimer's disease or general cognitive aging. Further research, including detailed mechanistic studies and eventual human trials, is warranted to fully explore its therapeutic utility.


pinealon apoptosis
Source: pubmed:28976148 · Ingested 2026-04-24 · Digest: gemini-2.5-flash